Stockreport

Enlivex Announces Authorization from the Danish Regulatory Agency for the Company's Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis [Yahoo...

Enlivex Therapeutics Ltd. - Ordinary Shares  (ENLV) 
PDF immunotherapy company, today announced that the Danish Medicines Agency (DKMA) authorized the expansion into Denmark of the Company's multi-country, randomized, controll [Read more]